Interview with Jack Schalken. PCA3 and its use as a diagnostic test in prostate cancer. Interview by Christine McKillop.

Suppr

超能文献

作者信息

Schalken Jack

出版信息

Eur Urol. 2006 Jul;50(1):153-4. doi: 10.1016/j.eururo.2006.04.021. Epub 2006 May 8.

DOI:10.1016/j.eururo.2006.04.021

PMID:16713069

Abstract

摘要

相似文献

Interview with Jack Schalken. PCA3 and its use as a diagnostic test in prostate cancer. Interview by Christine McKillop.

Eur Urol. 2006 Jul;50(1):153-4. doi: 10.1016/j.eururo.2006.04.021. Epub 2006 May 8.

Re: Christine McKillop. Interview with Jack Schalken: PCA3 and its use as a diagnostic test in prostate cancer. Eur Urol 2006;50:153-154.回复：克里斯汀·麦基洛普。杰克·沙尔肯访谈：PCA3及其在前列腺癌诊断检测中的应用。《欧洲泌尿外科杂志》2006年；50卷：153 - 154页

Eur Urol. 2007 Mar;51(3):860-2. doi: 10.1016/j.eururo.2006.08.053. Epub 2006 Oct 10.

Molecular PCA3 diagnostics on prostatic fluid.前列腺液的分子PCA3诊断

Prostate. 2007 Jun 1;67(8):881-7. doi: 10.1002/pros.20564.

The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance.直肠指检后尿沉渣的时间分辨荧光法PCA3检测；荷兰多中心诊断性能验证

Clin Cancer Res. 2007 Feb 1;13(3):939-43. doi: 10.1158/1078-0432.CCR-06-2679.

[Value of urinary PCA3 test for prostate cancer diagnosis].[尿液PCA3检测在前列腺癌诊断中的价值]

Prog Urol. 2008 May;18(5):259-65. doi: 10.1016/j.purol.2008.03.029. Epub 2008 May 16.

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy.用于接受重复活检男性前列腺癌的PCA3分子尿液检测

Urology. 2007 Mar;69(3):532-5. doi: 10.1016/j.urology.2006.12.014.

A multicenter evaluation of the PCA3 molecular urine test: pre-analytical effects, analytical performance, and diagnostic accuracy.PCA3分子尿液检测的多中心评估：分析前影响因素、分析性能及诊断准确性。

Clin Chim Acta. 2008 Mar;389(1-2):1-6. doi: 10.1016/j.cca.2007.11.003. Epub 2007 Nov 17.

PCA3 improves diagnosis of prostate cancer.PCA3可改善前列腺癌的诊断。

Practitioner. 2007 Jan;251(1690):18, 21, 23.

Re: Hessels D, Klein Gunnewiek JMT, van Oort I, Karthaus HFM, van Leenders GJL, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003;44:8-16.

Eur Urol. 2004 Aug;46(2):271-2. doi: 10.1016/j.eururo.2004.03.003.

PCA3: a molecular urine assay for predicting prostate biopsy outcome.PCA3：一种用于预测前列腺活检结果的分子尿液检测方法。

J Urol. 2008 Apr;179(4):1587-92. doi: 10.1016/j.juro.2007.11.038. Epub 2008 Mar 4.

引用本文的文献

Rho GTPase activating protein 21-mediated regulation of prostate cancer associated 3 gene in prostate cancer cell.Rho GTPase 激活蛋白 21 介导调控前列腺癌细胞中前列腺癌相关基因 3。

Braz J Med Biol Res. 2024 Jun 17;57:e13190. doi: 10.1590/1414-431X2024e13190. eCollection 2024.

Electrochemical and optical detection and machine learning applied to images of genosensors for diagnosis of prostate cancer with the biomarker PCA3.电化学和光学检测以及机器学习在基于生物标志物 PCA3 的用于前列腺癌诊断的基因传感器图像中的应用。

Talanta. 2021 Jan 15;222:121444. doi: 10.1016/j.talanta.2020.121444. Epub 2020 Aug 7.

Biomarkers in prostate cancer: new era and prospective.前列腺癌中的生物标志物：新时代与展望

Med Oncol. 2014 Aug;31(8):140. doi: 10.1007/s12032-014-0140-3. Epub 2014 Jul 22.

The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis.基于 PCA3 检测的前列腺癌重复活检及其截断值：系统评价和荟萃分析。

Asian J Androl. 2014 May-Jun;16(3):487-92. doi: 10.4103/1008-682X.125390.

PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.PCA3 非编码 RNA 参与控制前列腺癌细胞的存活，并调节雄激素受体信号。

BMC Cancer. 2012 Nov 6;12:507. doi: 10.1186/1471-2407-12-507.

[Molecular genetic markers for prostate cancer. Evidence in fine needle biopsies for improved confirmation of the diagnosis].[前列腺癌的分子遗传标记物。细针穿刺活检中用于改善诊断确认的证据]

Urologe A. 2008 Sep;47(9):1208-11. doi: 10.1007/s00120-008-1837-8.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验